| Literature DB >> 19059790 |
Maria Giulia Zampino1, Roberto Labianca, Giordano D Beretta, Elena Magni, Gemma Gatta, Maria Cristina Leonardi, Antonio Chiappa, Roberto Biffi, Filippo de Braud, Jacques Wils.
Abstract
Rectal cancer is an important tumour from an epidemiological point of view and represents the benchmark for an optimal use of integrated treatments (surgery, radiotherapy and chemotherapy) in the oncological practice. The conventional use of total mesorectal excision and the integration with radiochemotherapy, better if preoperatively, are now able to increase survival, to decrease the occurrence of pelvic recurrence and to ameliorate the quality of life of patients. Updated recommendations for the management of these patients are here reported.Entities:
Mesh：
Substances：
Year: 2008 PMID： 19059790 DOI： 10.1016/j.critrevonc.2008.10.010
Source DB: PubMed Journal: Crit Rev Oncol Hematol ISSN： 1040-8428 Impact factor: 6.312